EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Mycophenolate mofetil in children with steroid-dependent and/or frequently relapsing nephrotic syndrome



Mycophenolate mofetil in children with steroid-dependent and/or frequently relapsing nephrotic syndrome



Annals of Saudi Medicine 25(5): 380-384



BACKGROUND: Mycophenolate mofetil (MMF) has emerged as a new agent for treatment of a variety of glomerular diseases. This study examines the safety and efficacy of MMF in treating pediatric patients with steroid-dependent (SD) and/or frequently relapsing (FR) nephrotic syndrome (NS).METHODS: We retrospectively reviewed the medical records of 18 patients with SDNS and/or FRNS treated with MMF for at least 3 months.

(PDF emailed within 1 workday: $29.90)

Accession: 012337529

Download citation: RISBibTeXText

PMID: 16270759



Related references

Evaluation of mycophenolate mofetil or tacrolimus in children with steroid sensitive but frequently relapsing or steroid-dependent nephrotic syndrome. Nephrology 21(1): 21-27, 2016

Mycophenolate mofetil therapy in frequently relapsing steroid-dependent and steroid-resistant nephrotic syndrome of childhood: current status and future directions. Pediatric Nephrology 20(10): 1376-1381, 2005

Mycophenolate Sodium for Children with Frequently Relapsing or Steroid Dependent Nephrotic Syndrome. Indian Pediatrics 54(10): 885-886, 2017

The Value of Monitoring the Serum Concentration of Mycophenolate Mofetil in Children with Steroid-Dependent/Frequent Relapsing Nephrotic Syndrome. Nephron 132(4): 327-334, 2016

Mycophenolate mofetil versus cyclosporin A in children with frequently relapsing nephrotic syndrome. Journal of the American Society of Nephrology 24(10): 1689-1697, 2013

Assessment of mycophenolate mofetil for treatment of frequently relapsing nephrotic syndrome in children. Zhong Nan Da Xue Xue Bao. Yi Xue Ban 32(6): 938-940, 2008

Multicenter trial of mycophenolate mofetil in children with steroid dependent or frequent relapsing nephrotic syndrome Report of the Southwest Pediatric Nephrology Study Group. Journal of the American Society of Nephrology 14(Abstracts Issue): 751A, November, 2003

Mycophenolate mofetil in children with frequently relapsing nephrotic syndrome: a report from the Southwest Pediatric Nephrology Study Group. Clinical Journal of the American Society of Nephrology 1(6): 1173-1178, 2007

Efficacy of mycophenolate treatment in adults with steroid-dependent/frequently relapsing idiopathic nephrotic syndrome. Clinical Kidney Journal 10(5): 632-638, 2017

Frequently relapsing nephrotic syndrome: treatment with mycophenolate mofetil. Pediatric Nephrology 19(1): 101-104, 2004

Should mycophenolate mofetil be administered prior to cyclosporine A as a steroid-sparing agent to children with steroid-dependent nephrotic syndrome?. Pediatric Nephrology, 2018

Mycophenolate mofetil and prednisolone therapy in children with steroid-dependent nephrotic syndrome. American Journal of Kidney Diseases 42(6): 1114-1120, 2003

Mycophenolate mofetil treatment in steroid resistant/relapsing nephrotic syndrome of childhood. Journal of the American Society of Nephrology 10(PROGRAM AND ABSTR ISSUE): 111A, Sept, 1999

Mycophenolate mofetil (MMF) as the first choice immunosuppressive drug in treatment of steroid-dependent nephrotic syndrome in children. Polski Merkuriusz Lekarski 44(262): 192-195, 2018

Efficacy of levamisole in children with frequently relapsing and steroid-dependent nephrotic syndrome. Indian Pediatrics 51(5): 371-373, 2014